Compare Cardinal Health Inc (CAH) vs J B Hunt Transport Services Inc (JBHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs J B Hunt Transport Services Inc — how do they compare? Cardinal Health Inc trades at $228.82 (market cap $53.89B), while J B Hunt Transport Services Inc trades at $281 (market cap $26.49B). The key difference: Cardinal Health Inc is far larger — about 2× J B Hunt Transport Services Inc's market cap, and Cardinal Health Inc pays the higher dividend (0.89%). Which is the better fit depends on your goals.
| CAH | JBHT | |
|---|---|---|
Market Cap | $53.89B | $26.49B |
Sector | Health | Industrials |
52-Week High | $239.71 | $290.07 |
52-Week Low | $146.04 | $130.65 |
Enterprise Value | $58.87B | $27.78B |
Dividend Yield | 0.89% | 0.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
JB Hunt Transport Services (JBHT) trades at $283.00, up 1.09% with a bullish technical signal from moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected soon. Valuation metrics show a P/E of 43.95 and P/S of 2.25, while profitability remains solid with 5.13% net margin and 16.68% ROE. Analyst consensus is strongly positive with 26 buy ratings and a $280.59 price target.
JBHT demonstrates consistent operational performance with stable cash flow generation, though revenue has declined from 2022 peaks. The stock faces valuation concerns with elevated P/E ratios, while freight market cyclicality presents ongoing business risks. Earnings momentum and strong analyst support provide upside potential, but investors should monitor Q2 earnings results for confirmation of growth trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →
